Polar Asset Management Partners’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Polar Asset Management Partners’s Portfolio CRXT Stock Details CRXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-275,000	Closed	-$2.77M	–	1494
2021 Q2	$2.77M	Hold	275,000	–	–	0.03%	509
2021 Q1	$2.77M	Buy	+275,000	New	+$2.77M	0.03%	455

Other funds holding CRXT

BCL

Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PIA

Powell Investment Advisors Miami, Florida $290M AUM 21.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Polar Asset Management Partners's CRXT Position: Q3 2021 in Review

Polar Asset Management Partners sold out of Clarus Therapeutics Holdings, Inc. Common Stock (CRXT) in Q3 2021, closing a stake of 275,000 shares — an estimated $2.77M sold.

Polar Asset Management Partners first reported a position in CRXT in Q1 2021 and held it in 2 quarters. The position peaked at $2.77M in Q2 2021. 12 funds tracked by Wall St. Rank hold CRXT as of Q3 2021.

Polar Asset Management Partners reported no remaining Clarus Therapeutics Holdings, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Polar Asset Management Partners sold 275,000 Clarus Therapeutics Holdings, Inc. Common Stock shares in Q3 2021, an estimated $2.77M.
Polar Asset Management Partners first reported a position in Clarus Therapeutics Holdings, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
Polar Asset Management Partners's Clarus Therapeutics Holdings, Inc. Common Stock position peaked at $2.77M in Q2 2021.
12 funds tracked by Wall St. Rank held Clarus Therapeutics Holdings, Inc. Common Stock as of Q3 2021.

Based on Polar Asset Management Partners's 13F filing for Q3 2021, filed 15 Nov 2021.